Fig. 2: Changes in selected immune gene expression-based signatures. | npj Breast Cancer

Fig. 2: Changes in selected immune gene expression-based signatures.

From: Palbociclib and letrozole for hormone receptor-positive HER2-negative breast cancer with residual disease after neoadjuvant chemotherapy

Fig. 2: Changes in selected immune gene expression-based signatures.

A–D Boxplot with the distribution of each score in tumor samples at the three timepoints (baseline, post-NAC, and surgery). E–G Boxplot with the distribution of each score stratified by CCCA status. CCCA was defined as a Ki67 ≤ 2.7% at surgery by central laboratory.

Back to article page